Transforming growth factor β1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa

Head and Neck

Volumn 23, Issue 9, 2001, Pages 725-732

  Pasini, Fatima S ^a   Mitzi Brentani, M ^a   Kowalski, Luiz P ^b   Federico, Miriam H H ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Head and neck squamous carcinoma; Transforming growth factor 1; Urokinase plasminogen activator and plasminogen activator inhibitor PAI 1

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HEAD CANCER; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NECK CANCER; NORTHERN BLOTTING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

EID: 0034892562     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.1103     Document Type: Article

References (37)

1. Estimates of the worldwide frequency of sixteen major cancers in 1980
2. Cancer incidence in São Paulo Country, Brazil
3. Predictive factors in head and neck cancer
4. The urokinase-type plasminogen activator system in cancer metastasis: A review
5. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β
6. Decreased expression of transforming growth factor beta receptors on head and neck squamous cell carcinoma tumor cells
7. Escape from transforming growth factor β control and oncogene cooperation in skin tumor development
8. Loss of expression of transforming growth factor β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion
9. Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: Regulation of plasminogen activator activity
10. Relationship between head and squamous cell carcinomas and fibrinolytic factors
11. Localization of plasminogen activators and their inhibitor in squamous cell carcinomas of the head and neck
12. Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: Association with mode of invasion and lymph node metastasis
13. Up-regulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx
14. Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients
15. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
16. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells
17. Plasminogen activator inhibitor type-1: Reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing
18. +RNA
19. Characterization of mouse ribosomal gene fragments purified by molecular cloning
20. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors
21. Production of TGFα and TGFβ by cultured keratinocytes, skin and oral squamous cell carcinomas - Potential autocrine regulation of normal and malignant cell proliferation
22. Expression of TGF-β 1 protein and mRNAs and the effect on the tissue remodeling in laringeal carcinomas
23. Discordant transforming growth factor β1 RNA and protein localization during chemical carcinogenesis of the skin
24. Overexpression of autocrine TGF-β 1 suppresses the growth of spindle epithelial cells in vitro and in vivo in the rat 4NQO model of oral carcinogenesis
25. Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity
26. In vitro urokinase type plasminogen activator levels and total plasminogen activator activity in squamous cell carcinomas of the head and neck
27. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis
28. Transforming growth factor-β 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro
29. Differential regulation of protease and extracellular matrix protein expression by transforming growth factor β 1 in non-small cell lung cancer cells and normal human bronchial epithelial cells
30. Transforming growth factor β 1 and sodium butyrate differentially modulate urokinase plasminogen activator and plasminogen activator inhibitor-1 in human breast normal and cancer cells
31. Divergent effect of TGFβ on growth and proteolytic modulation of human prostatic cancer cell lines
32. Regulation of plasminogen activator system in non-small cell lung cancer cell lines by growth factors EGF, TGF-α and TGF-β
33. Genetic integrity of transforming growth factor β (TGF-β) receptors in cervical carcinoma cell lines: Loss of growth sensitivity but conserved transcriptional response to TGF-β
34. Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of uterus
35. Plasminogen activators, integrins and the coordinated regulation of cell adhesion and migration
36. Urokinase-type-plasminogen-activator (uPA) production by human breast (myo) fibroblasts in vitro: Influence of transforming growth factor-β1 (TGFβ1) compared with factor(s) released by human epithelial-carcinoma cells
37. Distinct chromosomal deleted regions defining different subsets of head and neck tumors